NEW YORK (GenomeWeb) – Bio-Techne announced today that it has agreed to acquire Advanced Cell Diagnostics for $250 million in cash, plus an additional consideration of $75 million if certain milestones are achieved.

The deal is expected to close on or about August 1, and will be financed through a combination of cash on hand and a revolving line of credit facility that Bio-Techne said it expects to obtain. The company expects the acquisition to be slightly dilutive to its adjusted earnings per share for fiscal year 2017, and accretive thereafter.  

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.